Literature DB >> 17237553

Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactions.

T C Theoharides1, D Kempuraj, M Tagen, M Vasiadi, C L Cetrulo.   

Abstract

Findings obtained using animal models have often failed to reflect the processes involved in human disease. Moreover, human cultured cells do not necessarily function as their actual tissue counterparts. Therefore, there is great demand for sources of human progenitor cells that may be directed to acquire specific tissue characteristics and be available in sufficient quantities to carry out functional and pharmacological studies. Acase in point is the mast cell, well known for its involvement in allergic reactions, but also implicated in inflammatory diseases. Mast cells can be activated by allergens, anaphylatoxins, immunoglobulin-free light chains, superantigens, neuropeptides, and cytokines, leading to selective release of mediators. These could be involved in many inflammatory diseases, such as asthma and atopic dermatitis, which worsen by stress, through activation by local release of corticotropin-releasing hormone or related peptides. Umbilical cord blood and cord matrix-derived mast cell progenitors can be separated magnetically and grown in the presence of stem cell factor, interleukin-6, interleukin-4, and other cytokines to yield distinct mast cell populations. The recent use of live cell array, with its ability to study such interactions rapidly at the single-cell level, provides unique new opportunities for fast output screening of mast cell triggers and inhibitors.

Entities:  

Mesh:

Year:  2006        PMID: 17237553     DOI: 10.1007/s12015-006-0021-z

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN: 1550-8943            Impact factor:   5.739


  223 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 2.  The role of mast cells in migraine pathophysiology.

Authors:  Theoharis C Theoharides; Jill Donelan; Kristiana Kandere-Grzybowska; Aphrodite Konstantinidou
Journal:  Brain Res Brain Res Rev       Date:  2005-07

3.  Neuropeptide regulation of the expression of immediate hypersensitivity.

Authors:  E J Goetzl; T Chernov; F Renold; D G Payan
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

4.  Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

Authors:  Sonia Varadaradjalou; Frédéric Féger; Nathalie Thieblemont; Nadine Ben Hamouda; Jean-Marie Pleau; Michel Dy; Michel Arock
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

Review 5.  Mast cells in the rheumatoid lesion--ringleaders or innocent bystanders?

Authors:  D E Wooley
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

6.  Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway.

Authors:  Jing Cao; Curtis L Cetrulo; Theoharis C Theoharides
Journal:  Mol Pharmacol       Date:  2005-12-06       Impact factor: 4.436

7.  Self-reported increase in asthma severity after the September 11 attacks on the World Trade Center--Manhattaan, New York, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-09-06       Impact factor: 17.586

8.  Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells.

Authors:  V Dimitriadou; M G Buzzi; M A Moskowitz; T C Theoharides
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

9.  Psychosocial factors, respiratory viruses and exacerbation of asthma.

Authors:  A Smith; K Nicholson
Journal:  Psychoneuroendocrinology       Date:  2001-05       Impact factor: 4.905

10.  Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression.

Authors:  J Boesiger; M Tsai; M Maurer; M Yamaguchi; L F Brown; K P Claffey; H F Dvorak; S J Galli
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  6 in total

Review 1.  Cellular models for disease exploring and drug screening.

Authors:  Zhi-Kun Li; Qi Zhou
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

Review 2.  The gestational power of mast cells in the injured tissue.

Authors:  Maria-Angeles Aller; Natalia Arias; Vicente Martínez; Patri Vergara; Jaime Arias
Journal:  Inflamm Res       Date:  2017-11-03       Impact factor: 4.575

Review 3.  Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.

Authors:  Andrea L Suárez; Jamison D Feramisco; John Koo; Martin Steinhoff
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

4.  IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors.

Authors:  Xiaoyang Hua; Kelly D Chason; Janki Y Patel; Warren C Naselsky; Stephen L Tilley
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

5.  Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation.

Authors:  Noam Rudich; Katya Ravid; Ronit Sagi-Eisenberg
Journal:  Front Immunol       Date:  2012-06-04       Impact factor: 7.561

6.  Generation of mast cells from mouse fetus: analysis of differentiation and functionality, and transcriptome profiling using next generation sequencer.

Authors:  Nobuyuki Fukuishi; Yuusuke Igawa; Tomoyo Kunimi; Hirofumi Hamano; Masao Toyota; Hironobu Takahashi; Hiromichi Kenmoku; Yasuyuki Yagi; Nobuaki Matsui; Masaaki Akagi
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.